Portrazza

Made by

• Eli Lilly

Active Ingredient

Necitumumab (genetical recombination)

Prospectus

Approval date

2019/6/18

Treats

• Non-small cell lung cancer

Dosages

• Portrazza Injection - 234695円／瓶